Vicarious Surgical (RBOTW) Capital Leases (2022 - 2023)
Vicarious Surgical (RBOTW) reported Capital Leases of $14.3 million for Q2 2023, down 6.32% year-over-year from $15.3 million in Q2 2022, and down 1.8% on a QoQ basis from $14.6 million in Q1 2023.
Vicarious Surgical (RBOTW) has 2 years of Capital Leases data on file, last reported at $14.3 million in Q2 2023.
- Quarterly Capital Leases fell 6.32% year-over-year to $14.3 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $14.3 million (down 6.32% YoY) and the FY2022 annual result came in at $14.8 million, changed N/A from the prior year.
- Capital Leases eased to $14.3 million in Q2 2023 per RBOTW's latest filing, from $14.6 million in the prior quarter.
- Across five years, Capital Leases topped out at $15.5 million in Q1 2022 and bottomed at $14.3 million in Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vicarious Surgical | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 14.33 Mn |
| Mar 31, 2023 | 14.59 Mn |
| Dec 31, 2022 | 14.83 Mn |
| Sep 30, 2022 | 15.07 Mn |
| Jun 30, 2022 | 15.30 Mn |
| Mar 31, 2022 | 15.52 Mn |